Single-Center Analysis of the First 304 Living-Donor Liver Transplantations in 3 Years

Basit Öğe Kaydı
dc.authoridToprak, Hüseyin İlksen/0000-0001-9293-8116
dc.authoridKutlu, Ramazan/0000-0001-7941-7025
dc.authoridÖzgör, Dinçer/0000-0001-8519-8869
dc.authoridBayindir, Yasar/0000-0003-3930-774X
dc.authoridKutlu, Ramazan/0000-0001-7941-7025
dc.authoridAtes, Mustafa/0000-0003-2821-453X
dc.authoridYILMAZ, Mehmet/0000-0002-5710-5263
dc.authorwosidToprak, Hüseyin İlksen/AAN-4023-2020
dc.authorwosidKayaalp, Cuneyt/AAH-1764-2021
dc.authorwosidYilmaz, Mehmet/AAF-6095-2021
dc.authorwosidKutlu, Ramazan/AAE-5219-2020
dc.authorwosidPiskin, Turgut/HKV-8614-2023
dc.authorwosidÖzgör, Dinçer/AAB-3523-2021
dc.authorwosidBayindir, Yasar/T-1523-2017
dc.contributor.authorYilmaz, Sezai
dc.contributor.authorKayaalp, Cuneyt
dc.contributor.authorAra, Cengiz
dc.contributor.authorYilmaz, Mehmet
dc.contributor.authorIsik, Burak
dc.contributor.authorAydin, Cemalettin
dc.contributor.authorOzgor, Dincer
dc.date.accessioned2024-08-04T20:37:52Z
dc.date.available2024-08-04T20:37:52Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground/Aims: Living donor liver transplantations (LDLT) is a definitive treatment for patients with end-stage liver disease (ESLD), especially in the countries with donation problem. Between April 2007 and April 2010, we performed LDLT in 289 patients. Fifteen of the cases required re-transplantations. This study evaluates these 304 consecutive LDLTs donor and recipient outcomes. Methodology: Complication rates and survival data of the recipients and donors of 304 LDLT cases were analyzed. Results: All donors are alive and well. Overall complication rate was 27%. Early postoperative recipient complication rate was 51%. Most frequent complication was infection. In the long-term there were 57 biliary stricture and 5 chronic bile fistula cases. Chronic and acute rejection attacks developed in 7 and 103 patients, respectively. Hepatic artery thrombosis rate was 8%. One, two and three year survival rates were 82%, 79% and 75%, respectively. Recipient mortality was 25%, mostly due to vascular complications, septic complications, liver dysfunction and chronic rejection. Conclusions: More than 150 liver tranplantations per year in a single center is a challenge in Turkey, where there is a shortage of deceased donor grafts. LDLT is a safe procedure for donors and effective for ESLD. Improvement in surgical technique would provide better outcomes.en_US
dc.identifier.doi10.5754/hge11290
dc.identifier.endpage1109en_US
dc.identifier.issn0172-6390
dc.identifier.issue125en_US
dc.identifier.pmid23478145en_US
dc.identifier.scopus2-s2.0-84885801911en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage1105en_US
dc.identifier.urihttps://doi.org/10.5754/hge11290
dc.identifier.urihttps://hdl.handle.net/11616/96238
dc.identifier.volume60en_US
dc.identifier.wosWOS:000330327700030en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherH G E Update Medical Publishing S Aen_US
dc.relation.ispartofHepato-Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLiving-donor liver transplantationen_US
dc.titleSingle-Center Analysis of the First 304 Living-Donor Liver Transplantations in 3 Yearsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu